Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL1006077 | 1.00 | — | — | |
| Trimethylammonium SCHEMBL28134710 | 0.95 | — | — | |
| Trimethylammonium SCHEMBL28158661 | 0.95 | — | — | |
| Trimethylammonium SCHEMBL11151838 | 0.95 | — | — | |
| Ethylene Glycol SCHEMBL28159568 | 0.82 | — | — | |
| 1,4-Butanediol SCHEMBL27608420 | 0.80 | SMN1; SMN2 (0.53) | TSHRMAPTALDH1A1SMN1; SMN2 | |
| Propanol SCHEMBL4232952 | 0.80 | — | — | |
| 1,3-Propanediol SCHEMBL9777722 | 0.80 | — | — | |
| Trimethylammonium SCHEMBL27801498 | 0.78 | ALDH1A1 (0.67) | TSHRMAPTALDH1A1SMN1; SMN2 | |
| Trimethylammonium SCHEMBL2439226 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835687-B2 | Method for preparation of 4,4′-dinitrodiphenylamine and 4,4′-bis(alkylamino)diphenylamine with the base catalyst complex | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2014-09-16 | — | — | US | claimed |
| US-8759587-B2 | Method for preparation of 4,4′-dinitrodiphenylamine and 4,4′-bis(alkylamino)diphenylamine by using 4-nitroaniline | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2014-06-24 | — | — | US | claimed |
| US-8835687-B2 | Method for preparation of 4,4′-dinitrodiphenylamine and 4,4′-bis(alkylamino)diphenylamine with the base catalyst complex | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20120157713-A1 | METHOD FOR PREPARATION OF 4,4'-DINITRODIPHENYLAMINE AND 4,4'-BIS(ALKYLAMINO)DIPHENYLAMINE WITH THE BASE CATALYST COMPLEX | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157713-A1 | METHOD FOR PREPARATION OF 4,4'-DINITRODIPHENYLAMINE AND 4,4'-BIS(ALKYLAMINO)DIPHENYLAMINE WITH THE BASE CATALYST COMPLEX | NAAA, HNF4A, ABAT | TSHR 3735/4885MAPT 2789/4885ALDH1A1 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.